JP2025500049A5 - - Google Patents

Info

Publication number
JP2025500049A5
JP2025500049A5 JP2024537171A JP2024537171A JP2025500049A5 JP 2025500049 A5 JP2025500049 A5 JP 2025500049A5 JP 2024537171 A JP2024537171 A JP 2024537171A JP 2024537171 A JP2024537171 A JP 2024537171A JP 2025500049 A5 JP2025500049 A5 JP 2025500049A5
Authority
JP
Japan
Prior art keywords
methyl
alkyl
bonded
group
fluoro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024537171A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025500049A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2022/047962 external-priority patent/WO2023127814A1/en
Publication of JP2025500049A publication Critical patent/JP2025500049A/ja
Publication of JP2025500049A5 publication Critical patent/JP2025500049A5/ja
Pending legal-status Critical Current

Links

JP2024537171A 2021-12-27 2022-12-26 置換キノリン誘導体 Pending JP2025500049A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN2021141500 2021-12-27
CNPCT/CN2021/141500 2021-12-27
PCT/JP2022/047962 WO2023127814A1 (en) 2021-12-27 2022-12-26 Substituted quinoline derivative

Publications (2)

Publication Number Publication Date
JP2025500049A JP2025500049A (ja) 2025-01-07
JP2025500049A5 true JP2025500049A5 (enExample) 2025-10-15

Family

ID=86998968

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024537171A Pending JP2025500049A (ja) 2021-12-27 2022-12-26 置換キノリン誘導体

Country Status (7)

Country Link
US (1) US20250084062A1 (enExample)
EP (1) EP4457227A4 (enExample)
JP (1) JP2025500049A (enExample)
CN (1) CN118488952A (enExample)
AU (1) AU2022428183A1 (enExample)
CA (1) CA3242198A1 (enExample)
WO (1) WO2023127814A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024057013A1 (en) * 2022-09-12 2024-03-21 Exscientia Ai Limited Nlrp3 modulators

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2685540C (en) * 2007-08-03 2018-10-16 Graham Michael Wynne Drug combinations for the treatment of duchenne muscular dystrophy
EP2295068A1 (en) * 2009-09-04 2011-03-16 Neurotune AG Modified agrin-fragment capable of restoring muscle strength for use as a medicament
WO2012064642A1 (en) * 2010-11-08 2012-05-18 Glaxosmithkline Llc Fatty acid synthase inhibitors
US10138248B2 (en) * 2016-06-24 2018-11-27 Incyte Corporation Substituted imidazo[2,1-f][1,2,4]triazines, substituted imidazo[1,2-a]pyridines, substituted imidazo[1,2-b]pyridazines and substituted imidazo[1,2-a]pyrazines as PI3K-γ inhibitors

Similar Documents

Publication Publication Date Title
JP2023537484A5 (enExample)
JP2022544714A5 (enExample)
JP2019510787A5 (enExample)
JP2022512482A5 (enExample)
JP2010510999A5 (enExample)
JP2020510015A5 (enExample)
JP2023508097A5 (enExample)
JP2004516314A5 (enExample)
JP2023549547A5 (enExample)
JP2011509309A5 (enExample)
RU2010136050A (ru) 2-аминохинолиновые производные для использования в качестве ингибиторов секретазы (васе)
JP2008510691A5 (enExample)
CA2628131A1 (en) Hydroxy and alkoxy substituted 1h-imidazoquinolines and methods
JP2019500352A5 (enExample)
RU2430923C2 (ru) Тиазолилдигидрохиназолины
JP2021514001A5 (enExample)
JP2012503621A5 (enExample)
JP2023522177A5 (enExample)
JP2022505645A5 (enExample)
JP2021535207A5 (enExample)
JP2013502431A5 (enExample)
JP2023544476A5 (enExample)
JP2013544276A5 (enExample)
JP2015514063A5 (enExample)
JP2010513434A5 (enExample)